NCT07831980Not yet recruiting
Blood Flow Restriction Aerobic Exercise for Balance and Anxiety in Parkinson's Disease
Investigating the Effects of Aerobic Exercise With Blood Flow Restriction on Dual-task Postural Control and Anxiety Modulation in Patients With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
Reducing balance problems and anxiety severity are the top two research uncertainties for people with Parkinson's disease (PD). Besides having a mutually aggravating relationship between postural impairment and anxiety severity, dual tasking is a critical condition that would increase postural instability and anxiety level concurrently. High-intensity aerobic exercise could improve balance and reduce anxiety. However, the training benefits from high-intensity aerobic exercise are limited in people with PD due to disease-related symptoms. Blood flow restriction (BFR) has been applied to low-intensity exercise. By creating localized hypoxia and increasing metabolic stress, BFR could facilitate aerobic system and neural adaptations. However, for the PD population, only one study applied BFR to aerobic exercise with the research design of a single-case report, let alone investigating the effects of BFR aerobic exercise on postural control and anxiety level under a dual-task condition. With the measurements of behavioral performance, subjective anxiety questionnaire, skin conductance response, and electroencephalogram (EEG), the purpose of the 3-year research project is to investigate the effects of BFR aerobic exercise on dual-task postural performance, anxiety, and related brain activities in people with PD. In the first year, the investigators will investigate the immediate effect of one bout of BFR aerobic exercise on dual-task postural control and anxiety level. In the second and third years, the investigators will investigate the long-term training effects of BFR aerobic exercise on dual-task postural control, anxiety modulation, brain plasticity, and patient satisfaction. The present project is expected to have significant contributions to gaining a better insight into the neural correlates of balance and anxiety with BFR aerobic exercise, particularly under dual-task conditions, and provide an optimized rehabilitation strategy for people with PD in clinical practice.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- First submitted
- 11 Sept 2026
- Start date
- 28 Sept 2026
- Primary completion date
- 31 Jul 2029
- Lead sponsor
- National Cheng-Kung University Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT07831980
What you commit to
- Study type: Interventional
- Planned participants: 54
- From 28 Sept 2026 to the primary completion date, 31 Jul 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindications to blood flow restriction (BFR), including a history of cardiopulmonary disease, pneumonia, varicose veins, diabetes mellitus, or intermittent claudication; uncontrolled/unstable hypertension; active smoking; or currently taking medications that increase the risk of blood clots.
- Presence of depressive symptoms that could influence postural control or anxiety assessments, defined as currently taking antidepressant medications or scoring \> 1 on item 1.3 (Depressed mood) of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part I.
Other illness
- History of neurosurgical procedures, such as Deep Brain Stimulation (DBS).
Other
- Color vision deficiency or color blindness, which interferes with the visual color discrimination task.
Who the study is looking for
- Diagnosed with idiopathic Parkinson's disease by a board-certified neurologist specializing in movement disorders.
- Early-to-moderate stage of Parkinson's disease, corresponding to Hoehn and Yahr Stages 1 to 3 in the on-medication state.
- Absence of other neurological or orthopedic conditions affecting balance and gait (e.g., stroke, vestibular disorders).
- Mini-Mental State Examination (MMSE) score ≥ 26, indicating intact cognitive function without significant cognitive impairment.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.